PRISM BioLab Co.,LTD (206A.T)

JPY 258.0

(0.0%)

Annual Balance Sheets

(In JPY)
Breakdown 2023 2022
Total Assets 1.21 Billion 1.74 Billion
Total Current Assets 1.19 Billion 1.73 Billion
Cash And Short Term Investments 1.13 Billion 1.68 Billion
Cash and Cash Equivalents 1.13 Billion 1.68 Billion
Short Term Investments - -
Net Receivables 40.24 Million -
Inventory 17.92 Million -
Other Current Assets 5.48 Million 1.69 Million
Total Non-Current Assets 13.82 Million 8.03 Million
Net PPE - -
Good Will And Intangible Assets - -
Good Will - -
Intangible Assets - -
Long-Term Investments - -
Tax Assets - -
Other Non Current Assets 13.82 Million -
Other Assets 1000.00 -
Total Liabilities 63.41 Million 65.22 Million
Total Current Liabilities 63.24 Million 65.05 Million
Account Payables 38.6 Million -
Tax Payables 1.21 Million 26.69 Million
Short Term Debt -51.76 Million -
Deferred Revenue 13.15 Million -
Other Current Liabilities 63.24 Million 65.05 Million
Total Non Current Liabilities 171 Thousand 172 Thousand
Long-Term Debt - -
Deferred Revenue Non Current - -
Deferred Tax Liabilities Non Current - -
Other Non Current Liabilities 171 Thousand 172 Thousand
Other Liabilities - -
Total Equity 1.14 Billion 1.67 Billion
Stock Holders Equity 1.14 Billion 1.67 Billion
Common Stock 12.24 Million 12.24 Million
Retained Earnings -493.22 Million 33.69 Million
Accumulated other comprehensive income 423 Thousand -
Common Stock Equity 1.14 Billion 1.67 Billion
Capital Lease Obligation - -
Total Investments 13.82 Million 8.03 Million
Total Debt - -
Net Debt -1.13 Billion -1.68 Billion

Balance Sheet Charts